Prostate cancer, accolades for two IOR researchers

A research project on prostate cancer conducted at the Institute of Oncology Research (IOR, affiliated to USI), won a PCF Challenge Award 2019 worth $1 million at the annual conference of the PCF Prostate Cancer Foundation, the leading U.S. agency in the field, on October 25 in Carlsbad, California. The study of the international research team, led by Prof. Andrea Alimonti, group leader at the IOR and Full professor at the USI Faculty of Biomedical Sciences, was published in the prestigious scie...
More

IOR receives important funding from SNSF to advance its prostate cancer research efforts

Dr. Giuseppina M. Carbone, Prostate Cancer Biology Group, receives a 4-year grant of 700’000 CHF from Swiss National Science Foundation (SNSF) to study a transcription factor that acts as tumor suppressor to prevent development of aggressive prostate tumors in men. Dr. Carbone has a longstanding record of accomplishment in investigating the role of ETS transcription factors in prostate cancer. In past years, Dr. Carbone has achieved major breakthroughs in identifying and demonstrating the tum...
More

Four-year Postdoctoral fellowship in Prof. Alimonti’s LAB

A 4-year postdoctoral fellowship is available from September 1st, 2019 in the lab of Prof. Andrea Alimonti at IOR (www.alimontilab.com) to study the role of tumorinfiltrating myeloid cells in prostate cancer and to develop novel effective immunotherapies for the treatment of prostate cancer. The Alimonti lab works on cancer immunology, in particular on the role played by tumor-infiltrating myeloid cells in cancer initiation, progression and treatment resistance (e.g. Di Mitri et al., Nature 2014...
More

Swiss Cancer Research grant to Dr. Luciano Cascione

Dr. Luciano Cascione, head of Bioinformatics Core Unit at the Institute of Oncology Research and at the Swiss Institute of Bioinformatics (SIB), has received a research grant by the Swiss Cancer Research to study an enigmatic and interesting class of non-coding RNA called ultra-conserved regions (UCRs) in B-cell lymphomas. UCRs are 100% identical (fully conserved) across human and rodent genomes suggesting an important evolutionarily conserved biological function. Using bioinformatic approaches ...
More